| Summary: | Wilco P Achterberg,1 Ane Erdal,2 Bettina S Husebo,2 Miriam Kunz,3 Stefan Lautenbacher4 1Department of Public Health and Primary Care, Leiden University Medical Center, RC Leiden, 2300, the Netherlands; 2Department of Global Public Health and Primary Care, University of Bergen, Bergen, 5020, Norway; 3Department of Medical Psychology, University of Augsburg, Augsburg, 86156, Germany; 4Department of Physical Psychology, University of Bamberg, Bamberg, GermanyCorrespondence: Wilco P AchterbergDepartment of Public Health and Primary Care, Leiden University Medical Center, Hippocratespad 21, Postzone V0-P, Room V6-76, PO Box 9600, RC Leiden, 2300, the NetherlandsTel +31 71 5268412/8427; + 31 6 23668980Email w.p.achterberg@lumc.nlAbstract: In dementia, neuropathological changes alter the perception and expression of pain. For clinicians and family members, this knowledge gap leads to difficulties in recognizing and assessing chronic pain, which may consequently result in persons with dementia receiving lower levels of pain medication compared to those without cognitive impairment. Although this situation seems to have improved in recent years, considerable geographical variation persists. Over the last decade, opioid use has received global attention as a result of overuse and the risk of addiction, while the literature on older persons with dementia actually suggests undertreatment. This review stresses the importance of reliable assessment and the regular evaluation and monitoring of symptoms in persons with dementia. Based on current evidence, we concluded that chronic pain is still undertreated in dementia.Keywords: pain, dementia, assessment, analgesic treatment
|
|---|